The man unlawfully billing Medicare for hundreds of millions of dollars as part of a cancer genetics and cardiovascular genetics testing scheme, according to the DOJ.

Protavio is leading the development of the IVD-grade test kit, while Repado is developing the test's analysis software.

Under the collaboration, Tampa, Florida-based Detect-Ion and Mayo Clinic Florida will work to identify biomarkers of Pseudomonas aeruginosa — an antibiotic-resistant bacterium that is a key cause of ...

The senator is asking stakeholders with relevant experience and knowledge of CPT coding contracts to respond to a questionnaire.

The initiative, which was initially launched in 2020, will fund efforts to develop AI tools to improve diagnosis of Lyme disease.

Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.

Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.

Jefferies analyst Tycho Peterson cited the large addressable market for the company's PreTRM blood test for assessing pregnant women's risk of preterm birth.

Alzpath said Monday that it has licensed a proprietary Alzheimer's disease biomarker to Siemens Healthineers for use in an assay for the brain disorder. The deal covers an antibody to ...

CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...

With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.